Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Optimal Medical Therapy Following Deep Venous Interventions: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. Journal of vascular and interventional radiology : JVIR Khaja, M. S., Obi, A. T., Sharma, A. M., Cuker, A., McCann, S. S., Thukral, S., Matson, J. T., Hofmann, L. V., Charalel, R., Kanthi, Y., Meek, M. E., Meissner, M. H., White, S. B., Williams, D. M., Vedantham, S. 2021

Abstract

The optimal medical management of patients following endovascular deep venous interventions remains ill-defined. As such, the SIR Foundation (SIRF) convened a multidisciplinary group of experts in a virtual Research Consensus Panel (RCP) to develop a prioritized research agenda regarding anti-thrombotic therapy following deep venous interventions. Panelists presented gaps in knowledge followed by discussion and ranking of research priorities based on clinical relevance, overall impact, and technical feasibility. The following research topics were identified as high priority: 1) characterization of biological processes leading to in-stent stenosis/re-thrombosis; 2) identification and validation of methods to assess venous flow dynamics and their effect on stent failure; 3) elucidation of the role of inflammation and anti-inflammatory therapies; and 4) clinical studies to compare anti-thrombotic strategies and improve venous outcome assessment. Collaborative, multicenter research is necessary to answer these questions and thereby enhance the care of patients with venous disease.

View details for DOI 10.1016/j.jvir.2021.09.009

View details for PubMedID 34563699